Sort
15,842 grants matching “pancreatic cancer”
Defining diverse roles of p53 in pancreatic cancer
$170,640Michael Paul Kim · University Of Tx Md Anderson Can Ctr · K08 · FY2019 · CA
The Role of NR5A2 in Pancreas Development and Disease
$170,640Sahar Nissim · Brigham And Women'S Hospital · K08 · FY2018 · DK
The Role of NR5A2 in Pancreas Development and Disease
$170,640Sahar Nissim · Brigham And Women'S Hospital · K08 · FY2017 · DK
The Role of NR5A2 in Pancreas Development and Disease
$170,640Sahar Nissim · Brigham And Women'S Hospital · K08 · FY2019 · DK
Defining diverse roles of p53 in pancreatic cancer
$170,640Michael Paul Kim · University Of Tx Md Anderson Can Ctr · K08 · FY2018 · CA
Stromal Periostin in Pancreatitis and Pancreas Cancer
$170,640Rosa F. Hwang · University Of Tx Md Anderson Can Ctr · K08 · FY2011 · CA
Stromal Periostin in Pancreatitis and Pancreas Cancer
$170,640Rosa F. Hwang · University Of Tx Md Anderson Can Ctr · K08 · FY2013 · CA
Cellular and Molecular Biology Core
$170,497Patricia E Gallagher · Wake Forest University Health Sciences · P01 · FY2009 · HL
Discovery of PPI inhibitors for the FAK FAT domain
$170,433Timothy A Marlowe · University Of Arizona · R21 · FY2024 · CA
CA: Administrative Core
$170,391Gloria M. Petersen · Mayo Clinic Rochester · P50 · FY2010 · CA
Taste Receptor Family 2 Member 9 as a novel target for imaging Cancer Associated Fibroblasts in pancreatic cancer
$170,361Kimberly A. Kelly · University Of Virginia · R21 · FY2019 · CA
Markers for Risk in Familial Pancreatic Cancer
$170,308Ralph H Hruban · Johns Hopkins University · P50 · FY2011 · CA
The role of progenitor cells in pancreatic acinar renewal and pre-malignant progression
$170,196Ravikanth Maddipati · University Of Pennsylvania · K08 · FY2017 · DK
Application of Mucolytic Therapy in Patient-Derived Models of Pseudomyxoma Peritonei
$170,194Mohammad Haroon Asif Choudry · University Of Pittsburgh At Pittsburgh · R21 · FY2019 · CA
Targeted neuroendocrine cancer therapy using Verrucarin A
$170,089Renata Jaskula-Sztul · University Of Alabama At Birmingham · R21 · FY2023 · CA
Administrative Equipment Supplement for Computational Models of the Human Cell Cycle to Reveal Disease Mechanism and Inform Treatment
$170,006Jeremy Purvis · Univ Of North Carolina Chapel Hill · R01 · FY2022 · GM
Chitosan-based Delivery and Immunopotentiation of Cancer Vaccines
$169,977David Zaharoff · University Of Arkansas At Fayetteville · K22 · FY2011 · CA
Sensitized screen to identify cooperating genes involved in pancreatic cancer
$169,950Arthur M. Buchberg · Thomas Jefferson University · R21 · FY2010 · CA
The Role of N-cadherin in Tumor Progresion
$169,950Glenn Lawrence Radice · Thomas Jefferson University · R21 · FY2009 · CA
Variations of calorie restriction for the prevention of pancreatic cancer
$169,950Susan Lanza-Jacoby · Thomas Jefferson University · R21 · FY2010 · CA
Divalent cation activation of the integrin-mediated malignant phenotype in pancre
$169,950Michael Bouvet · University Of California, San Diego · R21 · FY2010 · CA
Targeting RON Receptor Signaling in Pancreatic Cancer
$169,950Andrew M Lowy · University Of California, San Diego · R21 · FY2009 · CA
Targeting RON Receptor Signaling in Pancreatic Cancer
$169,950Andrew M Lowy · University Of California, San Diego · R21 · FY2010 · CA
ANTI-GANGLIOSIDE IgM IN DIAGNOSING PROSTATE CANCER
$169,920John Wayne Cancer Institute · R21 · FY2005 · CA
Studies of Attenuated Salmonella with IL-2 against pancreatic cancer
$169,875Daniel Alan Saltzman · University Of Minnesota · R21 · FY2009 · CA